Ironwood Pharmaceuticals (IRWD) Amortization of Deferred Charges (2016 - 2026)
Ironwood Pharmaceuticals' Amortization of Deferred Charges history spans 13 years, with the latest figure at $418000.0 for Q4 2025.
- On a quarterly basis, Amortization of Deferred Charges rose 0.72% to $418000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.7 million, a 12.39% decrease, with the full-year FY2025 number at $1.7 million, down 12.39% from a year prior.
- Amortization of Deferred Charges hit $418000.0 in Q4 2025 for Ironwood Pharmaceuticals, roughly flat from $418000.0 in the prior quarter.
- Over the last five years, Amortization of Deferred Charges for IRWD hit a ceiling of $6.1 million in Q4 2021 and a floor of $350000.0 in Q3 2024.
- Historically, Amortization of Deferred Charges has averaged $1.6 million across 5 years, with a median of $500500.0 in 2022.
- Biggest five-year swings in Amortization of Deferred Charges: tumbled 93.49% in 2022 and later soared 46.75% in 2023.
- Tracing IRWD's Amortization of Deferred Charges over 5 years: stood at $6.1 million in 2021, then tumbled by 93.49% to $400000.0 in 2022, then soared by 46.75% to $587000.0 in 2023, then fell by 29.3% to $415000.0 in 2024, then rose by 0.72% to $418000.0 in 2025.
- Business Quant data shows Amortization of Deferred Charges for IRWD at $418000.0 in Q4 2025, $418000.0 in Q3 2025, and $416000.0 in Q2 2025.